We are live on ! Find out more
IIM

Ipswich Investment Management Portfolio holdings

AUM $474M
1-Year Est. Return 35.58%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+35.58%
3 Year Est. Return
+92.81%
5 Year Est. Return
+126.14%
10 Year Est. Return
+1,334%
AUM
$202M
AUM Growth
-$7.88M
Cap. Flow
-$11.7M
Cap. Flow %
-5.81%
Top 10 Hldgs %
29.36%
Holding
397
New
2
Increased
22
Reduced
64
Closed
263

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.55M
2
NKE icon
Nike
NKE
+$998K
3
WFC icon
Wells Fargo
WFC
+$480K
4
TROW icon
T. Rowe Price
TROW
+$450K
5
NVS icon
Novartis
NVS
+$439K

Sector Composition

Rank Sector Weight
1 Healthcare 18.78%
2 Energy 15.68%
3 Industrials 11.65%
4 Financials 11.64%
5 Consumer Staples 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
26
Marriott International
MAR
$92.3B
$2.71M 1.34%
40,828
+1,515
+4% +$102K
AKAM icon
27
Akamai
AKAM
$15.9B
$2.69M 1.33%
48,042
-630
-1% -$33.2K
CAT icon
28
Caterpillar
CAT
$387B
$2.66M 1.32%
35,120
+13,587
+63% +$1.02M
MRK icon
29
Merck
MRK
$318B
$2.64M 1.31%
47,990
-581
-1% -$30.9K
CL icon
30
Colgate-Palmolive
CL
$74.4B
$2.62M 1.3%
35,770
+101
+0.3% +$7.19K
CHD icon
31
Church & Dwight Co
CHD
$24.5B
$2.58M 1.27%
50,052
-960
-2% -$46.3K
CELG
32
DELISTED
Celgene Corp
CELG
$2.48M 1.23%
25,177
+315
+1% +$32.6K
DUK icon
33
Duke Energy
DUK
$97.3B
$2.44M 1.21%
28,408
-5,476
-16% -$438K
GILD icon
34
Gilead Sciences
GILD
$165B
$2.44M 1.2%
29,185
-1,356
-4% -$120K
AIG icon
35
American International
AIG
$41.3B
$2.43M 1.2%
45,930
-1,174
-2% -$64.8K
TJX icon
36
TJX Companies
TJX
$178B
$2.31M 1.14%
59,860
-292
-0.5% -$11.1K
EOG icon
37
EOG Resources
EOG
$70.7B
$2.27M 1.12%
27,166
-500
-2% -$40.1K
BMY icon
38
Bristol-Myers Squibb
BMY
$132B
$2.2M 1.09%
29,892
-1,620
-5% -$114K
NVS icon
39
Novartis
NVS
$297B
$2.15M 1.06%
29,081
-6,361
-18% -$439K
T icon
40
AT&T
T
$163B
$1.95M 0.96%
59,707
-1,324
-2% -$39.4K
PEP icon
41
PepsiCo
PEP
$190B
$1.79M 0.88%
16,862
-165
-1% -$17K
LH icon
42
Labcorp
LH
$25.9B
$1.72M 0.85%
15,350
+1,543
+11% +$166K
JPM icon
43
JPMorgan Chase
JPM
$950B
$1.68M 0.83%
27,072
-321
-1% -$20.1K
SIVB
44
DELISTED
SVB Financial Group
SIVB
$1.66M 0.82%
17,460
+1,030
+6% +$105K
TROW icon
45
T. Rowe Price
TROW
$24.3B
$1.59M 0.79%
21,864
-6,040
-22% -$450K
VZ icon
46
Verizon
VZ
$196B
$1.57M 0.77%
28,043
-1,175
-4% -$60.9K
NKE icon
47
Nike
NKE
$61.9B
$1.54M 0.76%
27,870
-17,520
-39% -$998K
KO icon
48
Coca-Cola
KO
$375B
$1.52M 0.75%
33,646
WFC icon
49
Wells Fargo
WFC
$264B
$1.52M 0.75%
32,201
-9,847
-23% -$480K
TTE icon
50
TotalEnergies
TTE
$190B
$1.29M 0.64%
16,045,949,786
-235,684,728
-1% -$23.6K

Similar funds

Ipswich Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Ipswich Investment Management held 397 positions worth $202M, down 3.8% from $210M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ipswich Investment Management withdrew a net $11.7M in Q2 2016, closing 263 positions and reducing 64 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $316K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Energy and Industrials.

Against the trend, Ipswich Investment Management opened a new position in Apple worth $5.44M.

  • Ipswich Investment Management's largest Q2 2016 buy was Apple: 227,580 shares worth $5.44M.
  • Ipswich Investment Management added most to Caterpillar in Q2 2016, an estimated $1.02M increase.
  • Ipswich Investment Management's biggest Q2 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $3.55M.
  • Ipswich Investment Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $316K.
  • Ipswich Investment Management's ten largest holdings make up 29% of its $202M portfolio in Q2 2016.
  • Ipswich Investment Management opened 2 new positions and closed 263 in Q2 2016.
  • Ipswich Investment Management's portfolio value fell 3.8% quarter-over-quarter to $202M.

Based on Ipswich Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.